Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of

Xiaosong Meng1, Benjamin Press2, Audrey Renson3

  • 1Department of Urology, NYU Langone Health, New York, NY.

Insights

The modified Charlson Comorbidity Index (mCCI) and body mass index (BMI) showed similar, poor predictive ability for complications after radical cystectomy (RC). Combining mCCI and BMI slightly improved prediction for adverse events in bladder cancer surgery.

Area of Science:

  • Urology
  • Oncology
  • Anesthesiology

Background:

  • Several comorbidity indexes, including the American Society of Anesthesiologists physical status classification system, modified Charlson Comorbidity Index (mCCI), and modified Frailty Index, are linked to complications after urologic surgery.
  • No prior research has directly compared the predictive accuracy of these indexes for postoperative complications specifically following radical cystectomy (RC) for bladder cancer.

Purpose of the Study:

  • To evaluate and compare the predictive performance of established comorbidity indexes and demographic factors for postoperative complications after radical cystectomy (RC).
  • To identify the most effective tools for predicting adverse outcomes in patients undergoing RC for bladder cancer.

Main Methods:

  • A retrospective review of 1516 patients undergoing elective RC for bladder cancer between 2005 and 2011 was conducted using the American College of Surgeons National Surgical Quality Improvement Program database.
  • The study assessed outcomes including minor/severe/infectious adverse events, overall adverse events, extended hospital stay, discharge to a higher care level, and mortality.
  • Receiver operating characteristic (ROC) curves and area under the curve (AUC) analyses were used to determine the discriminative ability of patient comorbidity indexes and demographic data.

Main Results:

  • The modified Charlson Comorbidity Index (mCCI) demonstrated the highest predictive value for any adverse event among the comorbidity indexes (AUC, 0.511).
  • Demographic factors, specifically body mass index (BMI) and sex, showed comparable predictive ability (AUC, 0.519).
  • Overall, all assessed indexes exhibited poor discriminative ability for predicting adverse events (AUC < 0.52), although combining BMI and mCCI offered marginal improvement.

Conclusions:

  • For radical cystectomy (RC), patient-derived modified Charlson Comorbidity Index (mCCI), body mass index (BMI), and sex possess similar, albeit poor, discriminative abilities for predicting perioperative adverse outcomes.
  • These easily obtainable factors are comparable to more complex tabulated indexes that are less practical for clinical use.
  • Both demographic factors and comorbidity indexes demonstrated limited predictive power for adverse events following RC.
Abstract

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Modified Boxplots00:57

Modified Boxplots

A standard box and whisker plot informs us about the spread of the data in a given sample. One can identify the minimum value, maximum value, first quartile value, second quartile or median value, and third quartile.
However, the box plot does not tell the reader about outliers - values that lie far from the center of the data. We can modify the standard box and whisker plot to identify the outliers and visualize the actual spread of the data in a sample.
Initially, we calculate the adjusted...
11.3K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.9K
The Sense of Self: Reflected Self-Appraisal and Social Comparison02:57

The Sense of Self: Reflected Self-Appraisal and Social Comparison

According to Charles Cooley, we base our image on what we think other people see (Cooley 1902). We imagine how we must appear to others, then react to this speculation. We don certain clothes, prepare our hair in a particular manner, wear makeup, use cologne, and the like—all with the notion that our presentation of ourselves is going to affect how others perceive us. We expect a certain reaction, and, if lucky, we get the one we desire and feel good about it. But more than that, Cooley...
56.2K
Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
95.5K
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
1